Mednax, Inc. MD
We take great care to ensure that the data presented and summarized in this overview for MEDNAX, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MD
View all-
Black Rock Inc. New York, NY13.7MShares$198 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$155 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY8.28MShares$120 Million2.67% of portfolio
-
Alliancebernstein L.P. New York, NY8.11MShares$118 Million0.03% of portfolio
-
State Street Corp Boston, MA3.54MShares$51.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.47MShares$50.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.27MShares$47.4 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.33MShares$33.7 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$28.1 Million0.0% of portfolio
-
Boston Partners Boston, MA1.56MShares$22.6 Million0.02% of portfolio
Latest Institutional Activity in MD
Top Purchases
Top Sells
About MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Insider Transactions at MD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 13
2024
|
Mark S Ordan |
SELL
Open market or private sale
|
Direct |
27,600
-16.6%
|
$414,000
$15.35 P/Share
|
Nov 08
2024
|
Mary Ann E Moore EVP, GC, Chief Admin Off & Sec |
SELL
Open market or private sale
|
Direct |
8,108
-5.63%
|
$129,728
$16.0 P/Share
|
Aug 30
2024
|
James D Swift Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,100
-6.13%
|
$111,000
$10.79 P/Share
|
Aug 27
2024
|
Laura A Linynsky |
SELL
Open market or private sale
|
Direct |
7,000
-18.52%
|
$77,000
$11.16 P/Share
|
Aug 12
2024
|
C Marc Richards EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,438
-9.05%
|
$174,380
$10.08 P/Share
|
Aug 09
2024
|
C Marc Richards EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32,562
-14.45%
|
$325,620
$10.08 P/Share
|
Jun 01
2024
|
Mary Ann E Moore EVP, GC, Chief Admin Off & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
68,400
+32.22%
|
-
|
Jun 01
2024
|
Lee Wood EVP, Natl & Market Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
813
-0.69%
|
$5,691
$7.31 P/Share
|
Jun 01
2024
|
Lee Wood EVP, Natl & Market Operations |
BUY
Grant, award, or other acquisition
|
Direct |
51,300
+30.28%
|
-
|
Jun 01
2024
|
C Marc Richards EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,760
+29.82%
|
-
|
Jun 01
2024
|
Curtis Pickert EVP, Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
2,332
-1.93%
|
-
|
Jun 01
2024
|
Curtis Pickert EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
751
-0.62%
|
$5,257
$7.31 P/Share
|
Jun 01
2024
|
Curtis Pickert EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,400
+36.04%
|
-
|
Jun 01
2024
|
James D Swift Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,165
+36.74%
|
-
|
May 09
2024
|
Mark S Ordan |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+9.94%
|
-
|
May 09
2024
|
Guy P Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+21.18%
|
-
|
May 09
2024
|
Thomas Mc Eachin |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+25.15%
|
-
|
May 09
2024
|
Michael A. Rucker |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+24.0%
|
-
|
May 09
2024
|
Laura A Linynsky |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+32.69%
|
-
|
May 09
2024
|
Shirley A Weis |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+33.76%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 536K shares |
---|
Open market or private sale | 112K shares |
---|---|
Payment of exercise price or tax liability | 57.9K shares |
Bona fide gift | 15.3K shares |